Addison disease Addisonian crisis emergency treatment in ...

Alright, let's get this Poodle stabilized. A 5-year-old collapsed Standard Poodle with bradycardia, hypothermia, K+ 7.8, and a Na:K ratio of 20 screams Addisonian crisis. This is a critical metabolic emergency, and hyperkalemia is the most immediate life threat.

Here’s the emergency stabilization protocol:

Emergency Stabilization Protocol for Addisonian Crisis

ABCs & Immediate Life Threats:

* Airway/Breathing: Ensure a patent airway. Given the collapse, mentation may be depressed, but respiratory effort isn't usually the primary issue unless severe shock is causing hypoperfusion to the respiratory muscles. Provide supplemental oxygen if SpO2 < 95% or if the patient is dyspneic.
* Circulation (THE PRIORITY): This dog is in severe hypovolemic shock with life-threatening hyperkalemia.
* IV Access: Place two large-bore IV catheters immediately (e.g., bilateral cephalic or jugular).
* Cardioprotection (Hyperkalemia): The K+ of 7.8 is dangerous, and the bradycardia is likely hyperkalemia-induced.
Administer Calcium Gluconate 10% at 0.5-1.5 mL/kg IV slow over 10-15 minutes. Monitor ECG continuously during administration. This is cardioprotective, stabilizing myocardial cell membranes, but does not* lower potassium.
* Shift Potassium Intracellularly:
* Administer Regular Insulin 0.25-0.5 U/kg IV followed immediately by a dextrose bolus (1-2 g per unit of insulin). This drives potassium into cells. Start a dextrose CRI (2.5-5%) after the bolus to prevent iatrogenic hypoglycemia, as insulin's effect on glucose lasts longer than the bolus.
* Alternatively, consider Terbutaline 0.01 mg/kg IM/SQ (beta-2 agonist) to shift potassium, but insulin/dextrose is generally preferred for severe cases.
* Fluid Resuscitation: This dog is profoundly hypovolemic. Aggressive fluid resuscitation is crucial to correct hypovolemia, improve renal perfusion, and promote potassium excretion.
* Use 0.9% Sodium Chloride (NaCl). It's the fluid of choice because it contains no potassium and has a high sodium concentration, which helps correct the hyponatremia typical of Addison's.
* Administer 10-20 mL/kg IV boluses and reassess after each bolus. Titrate to effect, aiming for improved heart rate, pulse quality, mucous membrane color, CRT, and mentation. Don't chase a "shock dose" number; resuscitate to endpoints. Expect to give significant volumes.
Bradycardia: The bradycardia should resolve as hyperkalemia is managed and hypovolemia is corrected. If severe bradycardia persists after* initial hyperkalemia treatment and fluid boluses, and is deemed vagally mediated or unresponsive, consider Atropine 0.04 mg/kg IV, but this is less common once the underlying issues are addressed.
* Disability (Neurological): Monitor mentation. It should improve with resolution of shock and hyperkalemia.
* Exposure (Temperature): The patient is hypothermic. Implement active warming strategies immediately (warm IV fluids, warm air blankets, Bair Hugger, warm water circulating blankets). Hypothermia impedes drug metabolism and recovery.

Corticosteroid Administration:

Administer Dexamethasone Sodium Phosphate (SP) 0.1-0.2 mg/kg IV. This provides immediate glucocorticoid support, which is vital for Addisonian patients in crisis. Dexamethasone SP does not* interfere with the ACTH stimulation test, allowing you to collect samples for definitive diagnosis after administration.

Diagnostics (When Stable Enough):

* Once the patient is more stable, collect blood for a full CBC, chemistry panel, electrolytes, and ACTH stimulation test. Collect baseline cortisol, administer synthetic ACTH (cosyntropin), and collect a post-stimulation cortisol sample 60 minutes later.

Maintenance Therapy: DOCP vs. Fludrocortisone

Once the patient is stabilized and the diagnosis confirmed, lifelong maintenance therapy is required.

* Desoxycorticosterone Pivalate (DOCP, e.g., Percorten-V, Zycortal):
* Mechanism: Pure mineralocorticoid replacement.
* Dosing: Typically 2.2 mg/kg SQ every 25-30 days, adjusted based on electrolyte monitoring.
* Pros: Convenient (monthly injection), excellent electrolyte control, generally reliable.
* Cons: Requires concurrent oral glucocorticoid (e.g., prednisone 0.1-0.2 mg/kg/day, often tapered to a physiologic dose or even q.o.d.) because DOCP only replaces mineralocorticoids. More expensive initially but can be cost-effective long-term.
* Fludrocortisone Acetate (e.g., Florinef):
* Mechanism: Synthetic corticosteroid with both mineralocorticoid and glucocorticoid activity.
* Dosing: Typically 0.01-0.02 mg/kg PO BID, adjusted based on electrolytes.
* Pros: Oral administration (some owners prefer), provides both mineralocorticoid and glucocorticoid activity in one drug (though supplemental prednisone is often still needed, especially initially or during stress). Less expensive than DOCP upfront.
* Cons: Daily dosing, potential for more variability in absorption, and often still requires supplemental prednisone for adequate glucocorticoid coverage, especially during stress or if the patient is symptomatic.

My preference for initial stabilization and long-term compliance is often DOCP + prednisone. The monthly injection provides consistent mineralocorticoid control, and the oral prednisone can be easily adjusted for stress or tapered to the lowest effective dose.

Lifelong Monitoring Plan

Addison's disease requires meticulous, lifelong monitoring.

Electrolytes (Na, K):

* Initial: Every 12-24 hours during crisis stabilization.
* DOCP: Recheck electrolytes (Na, K) 10-14 days after the first injection, then just before the next scheduled injection (day 25-30). Adjust DOCP dose or frequency based on these values. Once stable, monitor every 3-6 months.
* Fludrocortisone: Recheck electrolytes 7-10 days after starting or dose change, then every 2-4 weeks until stable. Once stable, monitor every 3-6 months.

Renal Values (BUN, Creatinine): Monitor alongside electrolytes. Addisonian crisis can cause pre-renal azotemia, which should resolve with fluid therapy and steroid replacement.

Clinical Signs: Owners must be vigilant for signs of recurrence or inadequate therapy (lethargy, weakness, vomiting, diarrhea, anorexia).

Prednisone Adjustment: The glucocorticoid dose (prednisone) should be the lowest effective dose. Owners should be instructed to increase the prednisone dose during periods of stress (e.g., travel, boarding, surgery, illness) to prevent a secondary crisis.

ACTH Stimulation Test: Not routinely needed for monitoring after diagnosis if electrolytes are well-controlled with DOCP. If using fludrocortisone and there are concerns about glucocorticoid deficiency, or if the patient is doing poorly, an ACTH stim can be repeated, but generally, clinical signs and electrolyte balance are the primary guides.

This is a manageable disease with proper treatment, but missing a dose or failing to adjust for stress can have dire consequences. Owner education is paramount. Get this Poodle warmed up, fluids flowing, K+ under control, and dexamethasone on board. We'll get through this.